Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 112

1.

Monocarboxylate transporter 2 (MCT2) as putative biomarker in prostate cancer.

Pértega-Gomes N, Vizcaíno JR, Gouveia C, Jerónimo C, Henrique RM, Lopes C, Baltazar F.

Prostate. 2013 May;73(7):763-9. doi: 10.1002/pros.22620. Epub 2012 Nov 28.

PMID:
23192371
[PubMed - indexed for MEDLINE]
2.

Monocarboxylate transporter 4 (MCT4) and CD147 overexpression is associated with poor prognosis in prostate cancer.

Pértega-Gomes N, Vizcaíno JR, Miranda-Gonçalves V, Pinheiro C, Silva J, Pereira H, Monteiro P, Henrique RM, Reis RM, Lopes C, Baltazar F.

BMC Cancer. 2011 Jul 25;11:312. doi: 10.1186/1471-2407-11-312.

PMID:
21787388
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Reliability of the 34βE12, keratin 5/6, p63, bcl-2, and AMACR in the diagnosis of prostate carcinoma.

Boran C, Kandirali E, Yilmaz F, Serin E, Akyol M.

Urol Oncol. 2011 Nov-Dec;29(6):614-23. doi: 10.1016/j.urolonc.2009.11.013. Epub 2010 Mar 2.

PMID:
20189848
[PubMed - indexed for MEDLINE]
4.

Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy.

Sung MT, Jiang Z, Montironi R, MacLennan GT, Mazzucchelli R, Cheng L.

Hum Pathol. 2007 Feb;38(2):332-41. Epub 2006 Nov 28.

PMID:
17134736
[PubMed - indexed for MEDLINE]
5.

Alpha-methylacyl-CoA racemase (AMACR) expression in normal prostatic glands and high-grade prostatic intraepithelial neoplasia (HGPIN): association with diagnosis of prostate cancer.

Ananthanarayanan V, Deaton RJ, Yang XJ, Pins MR, Gann PH.

Prostate. 2005 Jun 1;63(4):341-6.

PMID:
15602744
[PubMed - indexed for MEDLINE]
6.

How often does alpha-methylacyl-CoA-racemase contribute to resolving an atypical diagnosis on prostate needle biopsy beyond that provided by basal cell markers?

Zhou M, Aydin H, Kanane H, Epstein JI.

Am J Surg Pathol. 2004 Feb;28(2):239-43.

PMID:
15043314
[PubMed - indexed for MEDLINE]
8.

Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.

Zhou M, Jiang Z, Epstein JI.

Am J Surg Pathol. 2003 Jun;27(6):772-8.

PMID:
12766580
[PubMed - indexed for MEDLINE]
9.

Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.

Stewart J, Fleshner N, Cole H, Sweet J.

J Clin Pathol. 2007 Jul;60(7):773-80. Epub 2006 Aug 17.

PMID:
16916997
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.

Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, Pienta KJ, Ghosh D, Chinnaiyan AM.

JAMA. 2002 Apr 3;287(13):1662-70.

PMID:
11926890
[PubMed - indexed for MEDLINE]
11.

Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer.

Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Ewing CM, Platz EA, Ferdinandusse S, Wanders RJ, Trent JM, Isaacs WB, De Marzo AM.

Cancer Res. 2002 Apr 15;62(8):2220-6.

PMID:
11956072
[PubMed - indexed for MEDLINE]
Free Article
12.

[Detection of AMACR (P504S), P63 and 34betaE12 cocktail in the early diagnosis of prostate cancer].

Yu T, Zhu SX, Zheng S, Chen SP.

Zhonghua Nan Ke Xue. 2007 Mar;13(3):222-5. Chinese.

PMID:
17393784
[PubMed - indexed for MEDLINE]
13.
14.

Using an AMACR (P504S)/34betaE12/p63 cocktail for the detection of small focal prostate carcinoma in needle biopsy specimens.

Jiang Z, Li C, Fischer A, Dresser K, Woda BA.

Am J Clin Pathol. 2005 Feb;123(2):231-6.

PMID:
15842047
[PubMed - indexed for MEDLINE]
Free Article
15.

Sensitivity of P504S/alpha-methylacyl-CoA racemase (AMACR) immunohistochemistry for the detection of prostate carcinoma on stored needle biopsies.

Vanguri VK, Woda BA, Jiang Z.

Appl Immunohistochem Mol Morphol. 2006 Sep;14(3):365-8.

PMID:
16932031
[PubMed - indexed for MEDLINE]
16.

Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy.

Farinola MA, Epstein JI.

Hum Pathol. 2004 Oct;35(10):1272-8.

PMID:
15492996
[PubMed - indexed for MEDLINE]
17.

Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.

Browne TJ, Hirsch MS, Brodsky G, Welch WR, Loda MF, Rubin MA.

Hum Pathol. 2004 Dec;35(12):1462-8.

PMID:
15619204
[PubMed - indexed for MEDLINE]
18.

Discovery and clinical application of a novel prostate cancer marker: alpha-methylacyl CoA racemase (P504S).

Jiang Z, Woda BA, Wu CL, Yang XJ.

Am J Clin Pathol. 2004 Aug;122(2):275-89. Review.

PMID:
15323145
[PubMed - indexed for MEDLINE]
Free Article
19.

Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy.

Magi-Galluzzi C, Luo J, Isaacs WB, Hicks JL, de Marzo AM, Epstein JI.

Am J Surg Pathol. 2003 Aug;27(8):1128-33.

PMID:
12883245
[PubMed - indexed for MEDLINE]
20.

The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.

Wang J, Weng J, Cai Y, Penland R, Liu M, Ittmann M.

Prostate. 2006 Jun 1;66(8):847-57.

PMID:
16491480
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk